Immunotherapy—particularly PD-1 inhibition with cemiplimab—is reshaping CSCC care by expanding into neoadjuvant and adjuvant ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of ...

A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...

The management of cutaneous squamous cell carcinoma (CSCC) is undergoing a notable shift, with systemic immunotherapy playing ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer ...

As colorectal cancer rates rise among young people, most patients with advanced disease still only have one treatment option: ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

Pancreatic tumors reprogram immune cells that normally shut down tumor-killing cells, according to a team at Oregon Health & ...

Treating some bowel cancer patients with immunotherapy before surgery improves survival and cuts the need for chemotherapy, ...

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to study results.Patients determined by a biology-guided AI model to be at high ...

Unsure what to expect from treatment? Experts share how to manage immunotherapy side effects for head and neck cancer to help you feel more prepared.